MedPath

STRIDES PHARMA GLOBAL PTE. LIMITED

πŸ‡ΈπŸ‡¬Singapore
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

10

HSA:10

Drug Approvals

VIRKIL FILM-COATED TABLETS 300 MG

Approval Date
May 8, 2020
HSA

STARFLU-75 CAPSULES 75 MG

Approval Date
May 14, 2019
HSA

MYCOPHENOLATE MOFETIL CAPSULES 250MG

Approval Date
Nov 20, 2014
HSA

FORMET TABLET 250mg

Approval Date
Mar 8, 2011
HSA

FORMET TABLET 850mg

Approval Date
Feb 25, 2011
HSA

Formet Tablet 500mg

Approval Date
Feb 25, 2011
HSA

CLARITRON TABLETS 500mg

Approval Date
Feb 25, 2011
HSA

STRIMOL TABLET 500 mg

Approval Date
Sep 3, 2009
HSA

REFRAT TABLET 500mg

Approval Date
Aug 20, 2009
HSA

STRIMOX-250 CAPSULE 250 mg

Approval Date
Oct 28, 2000
HSA

Clinical Trials

No trials found

News

Strides Pharma Partners with Kenox to Expand US Nasal Spray Portfolio

Strides Pharma Science's Singapore subsidiary has entered a strategic product development partnership with Kenox Pharmaceuticals to develop multiple nasal spray products for the US market across diverse therapeutic areas.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.